September 19, 2006 - ASM Sends Letter to Congressman Barton on NIH Reauthorization

The ASM sent a letter to Congressman Joe Barton on the NIH Reauthorization legislation supporting the proposed increases in NIH funding

September 10, 2002 - NSF FY 2003 Funding for the Biological Sciences Directorate

November 10, 2015 - ASM Recommendations for the FDA FY 2016 Budget

The ASM sent funding recommendations to the Committees on Appropriations for the FDA FY 2016 budget.  

November 8, 2002 - Research and Public Health Programs Appropriations for FY 2003

October 29, 2015 - White House Releases New Memorandum on Biosafety and Biosecurity Measures

The White House released a memorandum on the next steps to enhance biosafety and biosecurity in the United States. The memo highlights the conduct of parallel federal and broad stakeholder reviews to generate specific recommendations to strengthen the U.S. government's biosafety and biosecurity practices and oversight system.

August 23, 2002 - ASM Recommendations on Biodefense Research Funded by the National Institute of Allergy and Infectious Diseases

October is National Biosafety Stewardship Month

The NIH announced that October 2015 is National Biosafety Stewardship Month (NBSM).

December 13, 2016 - Listening Session with the FDA Commissioner

Janet Shoemaker and Kimberly Walker from ASM participated in a listening session with FDA Commissioner Robert Califf on rare diseases.

October 6, 2015 - ASM Letter in Response to the Antimicrobial Resistance Rapid Point of Care Diagnostic Test Challenge

The Department of Health and Human Services (HHS) is  holding a prize competition in which up to $20 million will be made available, subject to the availability of funds, for the delivery of one or more successful rapid point-of-care diagnostics that may be used by health care providers to identify bacterial infections.  The National Institutes of Health (NIH) and the Biomedical Advanced Research and Development Authority (BARDA) are sponsoring the prize competition and invited public comments regarding the technical criteria and performance characteristics of the diagnostics for which the prize will be offered.  The development and use of rapid, point-of-care, and innovative diagnostic tests for identification and characterization of resistant bacteria was a goal identified in the National Strategy for Combating Antibiotic-Resistant Bacteria released in September 2014  and addressed in the National Action Plan for Combating Antibiotic-Resistant Bacteria released in March 2015.The Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are contributing technical and regulatory expertise to develop the award evaluation process.

December 2, 2016 - 21st Century Cures Bill Passes House

The 21st Century Cures Act passed the House of Representatives on November 30.  It authorizes $4.8 billion over a ten year period for targeted initiatives at the NIH and $500 million for the FDA.  The bill is expected to be voted on in the Senate the week of December 5.  The Office of Public Affairs has prepared an analysis of the bill's provisions.

September 22, 2015 – ASM Comments on Cost Increase for the Drug Pyrimethamine

The ASM sent a letter to Turing Pharmaceuticals regarding the company’s recent 5,000 percent cost increase for the decades old generic drug pyrimethamine (Daraprim).

November 10, 2016 - ASM and PASCV Comment on Transplant Virus Testing

The ASM and Pan American Society for Clinical Virology (PASCV)  comment on reclassification of tests for the measurement of virus DNA levels in transplant-associated infections.

September 18, 2015 - ASM Sends Letter to Members of Congress on Antibiotic Tax Credit Bill

The ASM sent a letter to Representatives Boustany and Thompson regarding their proposed Antibiotic and Rapid Diagnostic Research and Development Tax Credit Act of 2015.  The legislation is designed to accelerate discovery of novel tools against drug resistant microbial pathogens.

October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation. 

Announcement of Public Consultation on Antimicrobial Resistance Rapid, Point-of-Care Diagnostic Test Challenge

As a part of the National Strategy for Combating Antibiotic-Resistant Bacteria the U.S. Department of Health and Human Services (HHS) announced a prize competition for the delivery of one or more successful rapid point-of-care diagnostics that may be used by health care providers to identify bacterial infections.


October 26, 2016 - ASM Joins PEW, IDSA and BD in Breakpoints Letter to Senate HELP Committee

ASM, PEW, IDSA and BD sent a letter to Senate HELP Committee Chairman Alexander and Ranking Member Murray asking them to consider language to streamline the process for updating breakpoints as they work to finalize the 21st Century Cures innovation legislation.

September 8, 2015 – ASM Poses Questions to CMS on Implementation of IQCP

The ASM submitted questions to the Administrator of the Centers for Medicare and Medicaid Services (CMS) on the implementation of Individualized Quality Control Plans (IQCPs) in the clinical microbiology laboratory.  The answers sought will allow ASM to assist clinical microbiologists prepare for implementation of their own IQCPs by the deadline of January 2016.  

October 17, 2016 - ASM, AMP and PASCV Express Concerns On New Molecular Test for Zika

The ASM, the Association for Molecular Pathology (AMP) and Pan American Society for Clinical Virology (PASCV) ask for data and clarification on the rRT-PCR assay for the testing of Zika, dengue and chikungunya viruses.

August 24, 2015 - ASM Comments on the List of Select Agents and Toxins

The ASM submitted comments to the Centers for Disease Control and Prevention on the possession, use, and transfer of select agents and toxins.  The comments addressed adding certain Influenza virus strains to the List of Select Agents and Toxins.

October 3, 2016 - White Paper on the Emergence of mcr-1 Plasmid-Mediated Colistin Resistance

The Committee on Laboratory Practices has developed a white paper to update members on colistin resistance and testing.

August 17, 2015 - ASM Comments on NIH RFI on the Framework for the NIH-wide Strategic Plan

The ASM submitted comments to the National Institutes of Health (NIH) RFI on the Framework for the NIH-wide Strategic Plan.  The comments will help NIH develop a 5-year strategic plan to outline a vision for biomedical research that will pursue fundamental knowledge about the nature and behavior of living systems and apply that knowledge to extend healthy life and reduce illness and disability.

September 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response

The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.

August 17, 2015 - ASM Comments on Department of State and Commerce Control Regulations for Certain Pathogens

The ASM submitted comments to the US Department of Commerce and the US State Department regarding the Category XIV materials (Toxicological Agents, Including Chemical Agents, Biological Agents, and Associated Equipment) included on the United States Munitions List and the Commerce Control List.

November 9, 2016 - ASM Recommendations to the Presidential Transition

The ASM sent policy recommendations to strengthen science, technology and public health in the United States.

July 16, 2015 - Payment Determinations for Calendar Year 2016 for New Clinical Laboratory Tests

The ASM presented recommendations to the Centers for Medicare & Medicaid Services at its annual public meeting on payment levels for new tests to be included in the 2016 Clinical Laboratory Fee Schedule.


August 30, 2016 - ASM Asks for Clarification on CLIA Personnel Regulations

ASM requests clarification on an April CMS State Survey Agency Directors memorandum regarding personnel policies on individuals performing non-waived tests.

July 24, 2015 - Request for Comments on NIH Strategic Plan Framework

The ASM has been asked to submit comments on the framework for the new National Institutes of Health strategic plan framework.

August 29, 2016 - ASM Letter Concerning UN Meeting on Antimicrobial Resistance

ASM sent a letter Samantha Power, the US Ambassador to the United Nations regarding the September 21 meeting of the UN General Assembly on antimicrobial resistance

August 5, 2015 - DoD Statement on Shipment of Anthrax to Labs

The Department of Defense (DoD) has requested that we post the following statement to ASM members regarding the inadvertent shipment of anthrax to laboratories.

ASM Urges Members to Support Petition Calling for United Nations to Collaborate to Combat Antimicrobial Resistance

The American Society for Microbiology will be participating in a September 21 meeting of the United Nations General Assembly to discuss how countries can cooperate to address antimicrobial resistance (AMR).  We urge ASM members to join the petition being circulated by IDSA on Change.org calling for the United Nations to work together to combat antimicrobial resistance in preparation for the meeting to discuss the topic.

May 19, 2015 - US Government Meeting on DURC

The US Government will hold a meeting for interested stakeholders to discuss implementation of the U.S. Government Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern on July 22. 

ASM Actions on Zika


Zika Funding Update

Zika tnSeptember 29, 2016 - Congress Passes Short-term Continuing Resolution and Funds Zika Response
The ASM Office of Public Affairs has summarized the details of the Continuing Resolution that includes funding to combat Zika.

Funding Alert: Contact Congress for Emergency Funding for Zika
The ASM has been working since February to urge congressional passage of a $1.9 billion emergency supplemental funding bill to respond to the Zika virus. The House and Senate passed Zika funding bills, but a conference agreement failed in the Senate over political controversy, stalling congressional passage of a final Zika funding bill before Congress left for the summer recess.  Please click the link above to contact your congressional delegation to urge immediate passage of a bipartisan emergency supplemental bill for Zika.

ASM Acts to Counter Zika Virus Outbreak
A summary of all Zika related ASM activities.

ASM Letters and Statements

August 5, 2016 - ASM Urges Public Health Actions and Funding to Combat Zika Emergency

July 18, 2016 - ASM Urges Congressional Action on Emergency Zika Funding
The ASM sent Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi a letter urging action on funding to combat the threat of Zika.

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika
The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding
The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

February 23, 2016 - ASM Endorses Letter Requesting Additional Funding for Zika
The ASM signed onto a letter sent to Congress supporting the White House request for supplemental funds to prepare for and respond to Zika.

February 12, 2016 - ASM Letter to Congress Regarding Zika Virus
The ASM sent a letter to Congress supporting the President's supplemental budget request of $1.8 billion to prepare and respond to the Zika virus outbreak.

 

 

 

May 8, 2015 - ASM Comments on the 21st Century Cures Act

The ASM sent comments on the 21st Centurey Cures Initiative to the House Committee on Energy and Commerce.

July 27, 2016 - ASM Asks VA for Clarification on Proposed Advance Practice Registered Nurse Duty Changes

ASM comments focus on Advance Practice Nurses ability to perform laboratory testing

April 21, 2015 - Energy & Environment Provisions in the America COMPETES Reauthorization Act of 2016

The ASM sent a letter to members of the House Committee on Science, Space and Technology about provisions in the America Competes Reauthorization Act of 2016, H.R. 1806.

ASM Urges Congressional Action on Emergency Zika Funding

The ASM sent a letter to Majority Leader McConnell and Minority Leader Reid, Speaker Ryan and Minority Leader Pelosi urging action on Zika funding legislation.

Government Travel Restrictions


Payment Determinations for Calendar Year 2017 for New Clinical Laboratory Tests

The ASM presented recommendations to the Centers for Medicare & Medicaid Services (CMS) at its annual Clinical Laboratory Fee Schedule public meeting determining payment levels for new tests for 2017.

April 9, 2015 - Laboratory Practices Committee Prepares Endoscopy Document

The PSAB Committee on Laboratory Practices prepared On The Question of Culturing of Duodenoscopes to address the unique challenges of pathogen identification in cases of infections associated with gastrointestinal endoscopy.

ASM Thanks Senate Subcommittee for NIH $2 Billion Budget Increase

The ASM sent letters to Senators Roy Blunt and Patty Murray thanking the Senate Labor/HHS Subcommittee for proposing a $2 Billion budget increase for the National Institutes of Health.

April 8, 2015 - NIH RFI on Funding and Strategies to Improve Sustainability of Research

The National Institutes of Health released a request for information (RFI) on optimizing funding policies and “other strategies to improve the impact and sustainability of the NIH-funded biomedical research enterprise.”  

May 24, 2016 - ASM Letter on DOE FY 2017 Appropriations

The ASM sent a letter to all members of the House of Representatives regarding DOE Provisions in House Amendment to S. 2012, the Energy Policy Modernization Act of 2016.

April 7, 2015 - ASM Comments on Impact of Select Agent Regulations

The ASM submitted comments in response to the Office of Science and Technology and Policy's request for comment on the impact that the Select Agent Regulations have had on science, technology, and national security, and on the benefits, costs, and limitations of the regulations.

May 18, 2016 - ASM Supports $1.9 Billion Emergency Funding to Combat Zika

The ASM sent a letter to Congress supporting the full $1.9 emergency funding request to combat Zika.

April 7, 2015 - ASM Comments on Select Agent Regulations Biennial Review

The ASM submitted comments to the Centers for Disease Control on the Biennial Review of the Select Agent Regulations.

ASM Members Meet with Senate Appropriations Chair

ASM volunteer leaders have on been Capitol Hill advocating for funding for the microbial sciences and their messages have accelerated congressional action on funding to address the Zika threat.

March 27, 2015 - White House Releases National Action Plan to Combat Antibiotic-Resistant Bacteria

On March 27, 2015 the White House released a comprehensive plan that identifies critical actions to be taken by Federal departments and agencies to combat the rise of antibiotic-resistant bacteria.

May 11, 2016 – ASM Comments on Department of Labor Employee Exemptions Definitions Impact on Research

The ASM sent a letter to Howard A. Shelanski, Ph.D., Administrator, Office of Information and Regulatory Affairs, Office of Management and Budget regarding the impact of the Department of Labor’s “Defining and Delimiting the Exemptions for Executive, Administrative, Professional, Outside Sales and Computer Employees” on research.

March 25, 2015 - ASM Letter Concerning CDC Biosafety Recommendations

The ASM sent a letter to Sylvia Mathews Burwell, Secretary of Health and Human Services, Department of Health and Human Services regarding CDC Biosafety recommendations.

ASM Acts to Counter Zika Virus Outbreak

A key role of a scientific association is to make the voices of its many individual members heard as a unified whole. Speaking on behalf of its 47,000 members worldwide, ASM has acted quickly to make the case to policy makers that we must take immediate and aggressive action against the emerging threat of Zika virus infection.

March 19, 2015 - Fiscal Year 2016 Appropriations Statements

The ASM submitted FY 2016 appropriations recommendations to the House and Senate Appropriations Committees.  

ASM Celebrates Medical Laboratory Professionals Week

ASM is a supporter of Medical Laboratory Professionals Week (MLPW) April 24-30, 2016 and salutes the more than 300,000 medical laboratory professionals around the country who perform and interpret more than 10 billion laboratory tests in the United States every year.

Department of Defense - FY 2016

 

April 11, 2016 - Soliciting Stakeholder Input for the BMBL Revision

The ASM sent a bulk e-mail to members soliciting input for the Biosafety in Microbiological and Biomedical Laboratories (BMBL) Revision.

Department of Energy - FY 2016

 

April 8, 2016 - ASM Letter on Zika and Emerging Infectious Disease Funding

The ASM sent a letter to Congress regarding emergency funding for the Zika outbreak.  The ASM supports providing new funding to fight public health emergencies.

National Science Foundation - FY 2016

 

Department of Defense - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

Food and Drug Administration - FY 2016

  

Department of Energy - FY 2017

The ASM submitted funding recommendations to Congress for the Department of Energy for fiscal year 2017.

U.S. Department of Agriculture - FY 2016

 

PSAB Funding Statements from 1997

The content of this page is restricted to ASM Members only.

Please login at the top-right or to become a member, join ASM.

Centers for Disease Control and Prevention - FY 2016

 

March 14, 2016 - ASM Comments on Select Agents and Toxins Regulations

The ASM sent comments to the Centers for Disease Control and Prevention (CDC) and the Animal and Plant Health Inspection Service (APHIS) regarding the biennial review of the List of Select Agents and Toxins and enhanced biosafety requirements. 

National Institutes of Health - FY 2016

 

ASM Funding Recommendations to Congress for Fiscal Year 2017

The ASM has submitted appropriation recommendations to Congress for federal agencies that support biomedical and public health research.

 

February 2, 2015 - President’s FY 2016 Budget Released

 

On February 2, President Obama released the Administration's FY 2016 budget proposal.

U.S. Department of Agriculture - FY 2017

The ASM submitted funding recommendations to Congress for the U.S. Department of Agriculture for fiscal year 2017.

January 28, 2015 - ASM Statement on the President’s Proposed 2016 Budget to Combat Antibiotic-Resistant Bacteria

The ASM released a statement on the President’s Proposed 2016 Budget to Combat Antibiotic-Resistant Bacteria.

National Science Foundation - FY 2017

The ASM submitted funding recommendations to Congress for the National Science Foundation for fiscal year 2017.

January 28, 2015 - ASM Endorses American Cures Act of 2015

The ASM sent a letter to Senator Richard Durbin (D-IL) endorsing the bill which would provide a five percent increase in funding for biomedical research supported by the National Institutes of Health and other federal agencies involved in biomedical research.

Food and Drug Administration - FY 2017

The ASM submitted funding recommendations to Congress for the Food and Drug Administration for fiscal year 2017.

2015 Statements and Testimony

Centers for Disease Control and Prevention - FY 2017

The ASM submitted funding recommendations to Congress regarding funding for the Centers for Disease Control and Prevention for fiscal year 2017.

January 8, 2015 - ASM and PASCV Comment on FDA Draft Guidance on LDTs

During the FDA Public Workshop “Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)” held on January 8-9, the ASM and the Pan American Society for Clinical Virology (PASCV) have commented on the implementation of this plan in clinical laboratories.

National Institutes of Health - FY 2017

The ASM submitted funding recommendations to Congress about the National Institutes of Health for FY 2017.

November 12, 2014 - ASM Supports FY 2015 Omnibus Appropriations Bill

The ASM sent a letter to members of Congress supporting passage of an FY 2015 Omnibus Appropriations bill to provide sustained and predictable federal funding for life science research and public health programs.

February 19, 2016 - ASM Letter Supports Increased AFRI Funding

The ASM sent a letter to Congress supporting a funding level of $700 million in the FY 2017 budget for the U.S. Department of Agriculture’s Agriculture and Food Research Initiative (AFRI).

November 7, 2014 - ASM Supports Emergency Funding to Combat Ebola Virus Outbreak

The ASM sent a letter to members of Congress supporting the Administration's $6.18 billion emergency funding request to combat the Ebola Virus outbreak. 

February 12, 2016 - ASM Letter to Congress Regarding Zika Virus

The ASM sent a letter to Congress supporting the President's supplemental budget request of $1.8 billion to prepare and respond to the Zika virus outbreak.

October 29, 2014 - ASM Statement on CDC Interim Guidance on Monitoring and Movement of Persons with Suspected Ebola Contact

The ASM issued a statement regarding the Centers for Disease Control and Prevention new Interim Guidance on Monitoring and Movement of Persons with Suspected Ebola Contact. 

2016 Statements and Testimony

Statements and Testimony from 2016

October 28, 2014 - White House Office of Science and Technology Policy Challenge to Develop Ebola Tools

The ASM sent a message to members about a White House Office of Science and Technology Policy program that solicits the global community to share innovative ideas that deliver practical and cost-effective innovations to address this crisis, to improve delivery of care, and stem the spread of Ebola virus disease.

2016 Statements and Testimony (2)

Statements and Testimony from 2016

October 17, 2014 - USG Launches Deliberative Process on Gain-of-Function Research

The White House Office of Science and Technology Policy announced that the U.S. government will undertake a deliberative process to assess the risks and benefits of certain gain-of-function (GOF) experiments with influenza, SARS, and MERS viruses in order to develop a new Federal policy regarding the funding of this research.

ASM Advisory to Members on the President’s FY 2017 Budget Request for Science and Public Health

The ASM Office of Public Affairs has prepared a summary of the Administration's FY 2017 budget request to Congress.  This summary includes special funding to combat the spread of the Zika virus.

October 2, 2014 - ASM Provides Ebola Resources for Clinical Laboratory Scientists

The ASM sent out a notice to clinical members about Ebola Virus resources.

December 22, 2015 - White House Releases National Action Plan for Combating Multidrug-Resistant Tuberculosis

The White House released a comprehensive plan that identifies critical actions to be taken by key Federal departments and agencies to combat the global rise of multidrug-resistant tuberculosis (MDR-TB).

September 26, 2014 - ASM Comments on NIGMS Strategic Plan

The ASM submitted comments on the strategic plan of the National Institute of General Medical Sciences.  

December 18, 2015 - Statement of the ASM on the FY 2016 Congressional Funding Increases for Research

Congress passed a $1.1 trillion spending package on December 18 that funds federal agencies for fiscal year 2016.  The omnibus appropriations bill (HR 2029) provides $32 billion for the National Institutes of Health (NIH), a $2 billion increase and nearly 7 percent over FY 2015.

September 25, 2014 - United States Government Policy for Institutional Oversight of Life Sciences DURC

On September 24 the United States Government issued the final US Policy for Institutional Oversight of Life Sciences Dual Use Research of Concern (DURC. The Office of Public Affairs sent a notice to members about the Oversight document.

December 8, 2015 - ASM Participates in CARB Working Group Meeting on Antibiotic Resistance

Susan Sharp, ASM President-Elect, presented answers to a series of questions on behalf of ASM to the meeting of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) Working Group on One Health Surveillance.   

September 23, 2014 - ASM Letter to the US HHS Concerning Scientific Resources in Response to the Ebola Virus Outbreak

The ASM sent a letter to Sylvia M. Burwell, Secretary US Department of Health & Human Services with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak.

November 4, 2015 - ASM Comments on Identifying Sources of Agricultural Innovation

That ASM sent comments to the Office of Science and Technology Policy (OSTP) regarding an a Request for Information (RFI) on Identifying Sources of Agricultural Innovation.

September 23, 2014 - ASM Letter to the UN Concerning Scientific Resources in Response to the Ebola Virus Outbreak

The ASM sent a letter to David Nabarro, M.D., Senior United Nations System Coordinator for Ebola Virus Disease with recommendations concerning scientific resources that are needed in response to the Ebola virus outbreak. 

ASM Advisory on the Report of the Fast-Track Action Committee on Mapping the Microbiome

The ASM sent out an advisory to members regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome.

September 23, 2014 - ASM Statement on National Strategy to Combat Antibiotic Resistant Bacteria

The ASM sent a statement on the National Strategy to Combat Antibiotic Resistant Bacteria, which was announced by President Obama on September 18, 2014 to ASM members, Congress and representatives of various federal agencies. 

December 2, 2015 - ASM Letter Regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome

The ASM sent a letter to Dr. John Holdren, Director of the Office of Science and Technology Policy and Shaun Donovan, Director of the Office of Management and Budget regarding the Report of the Fast-Track Action Committee on Mapping the Microbiome.  The report was published by the Life Sciences Subcommittee of the National Science and Technology Council.

September 17, 2014 - ASM Statement on Ebola Response

The ASM sent a statement on the Ebola response to members.  

November 19, 2015 - ASM Comments on Proposed Changes to Human Subject Protection Regulations (Common Rule)

ASM applauds proposed changes in the Human Subject Protection Regulations that would exclude the use of spent, de-identified human specimens for routine validation of diagnostic tests, as well as other quality assurance activities and asks that that this exclusion from oversight be expanded to include all research on de-identified specimens that do not involve analysis of human genetic material.

September 17, 2014 - ASM Statement on Ebola Response

The ASM sent a statement to members of Congress regarding the response to the Ebola outbreak in Western Africa encouraging additional support for research and public health programs.

TPL_asm2013_SEARCH

137

Joomla! Debug Console